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ABSTRACT
Objectives: Controlled ovarian hyperstimulation is an important step in infertility treatment. In some cases, however, ovar-
ian hyperstimulation syndrome (OHSS) can occur. In its severe forms, ascites is likely to develop, associated with dyspnea. 
The aim of this study was to explore the usefulness of Ascites Index (AsI), a new tool for quantitative determination of ascites 
in patients with OHSS, to obtain data for planning further trials.
Material and methods: Twelve patients with OHSS and ascites were included in the study. All patients were admitted 
to the hospital because of abdominal pain and dyspnea due to increasing ascites. Ultrasound measurements of ascites 
extent were performed in four external quadrants of the abdomen. Pockets of free fluid were measured. The obtained 
values were totaled, forming the Ascites Index (AsI), similarly to the amniotic fluid index. Because of dyspnea, paracentesis 
was performed in all cases.
Results: Median AsI at which patients reported dyspnea was 29.0 cm (range 21.6–38.6 cm). At AsI values less than 21.6 cm, 
no dyspnea was observed in any of the 12 studied patients. To avoid complications, 2000 mL of ascitic fluid was collected 
in each patient. After paracentesis, range of AsI decreased to 12.1–14.5 cm.
Conclusions: The proposed AsI seems to be a promising tool for estimating and monitoring the ascites extent in OHSS. 
It can be estimated using basic ultrasound equipment. AsI requires further studies for standardization and transferability 
to other causes of ascites.
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INTRODUCTION
Ascites is a condition in which an exudate or transudate 
accumulates in the peritoneal cavity. In normal conditions, 
the fluid is produced in the peritoneal cavity in a continuous 
manner. The fluid produced moistens the serosa, facilitating 
the viscera slide and is subsequently absorbed. In physi-
ological conditions, about 2/3 of fluid from the peritoneal 
cavity is absorbed into the open lymphatic canals of the 
diaphragm, reticulum and peritoneum and thanks to nega-
tive thoracic pressure is transported to the thoracic spinal 
canal and left venous angle via the mediastinal trunks. The 
amount of fluid depends on portal pressure, plasma oncotic 
pressure, water and sodium retention, quantity of lymph 
in the body as well as permeability of capillaries and is 
estimated at about 50 mL. When the production of fluid in 
the peritoneal cavity is bigger than its absorption, ascites 
develops [1–3].
Controlled ovarian hyperstimulation is an important pro-
cedure used for the treatment of infertility. In some cases, the 
procedure can be complicated by ovarian hyperstimulation 
syndrome (OHSS). OHSS manifests as marked enlargement of 
ovaries, protein-rich fluid accumulation into body cavities and 
interstitial space (“third space”), which results in condensation 
of blood concentration and its decreased volume. Accumula-
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tion of protein-rich fluid in the “third space” leads to abdomi-
nal distention and increased intra-abdominal pressure. Fully 
symptomatic OHSS can be complicated by ascites, pericar-
dial exudate, tachycardia with tachypnea, hemorrhage from 
a ruptured ovary, renal failure, oliguria, hypovolemia, throm-
boembolic episodes, ischemic stroke, adult acute respiratory 
distress syndrome, and death. The etiopathogenesis of OHSS 
has not been fully elucidated. Increased capillary permeability 
seems essential, caused by substances increasing capillary 
permeability triggered by human chorionic gonadotropin 
(hCG), which leads to ascites. In its severe and critical forms, 
the fluid also occurs in the other body cavities. There are sev-
eral vasoactive substances: histamine, serotonin, prostaglan-
dins and prolactin. It is currently believed that interleukins 
are crucial for the development of ascites in OHSS, including 
the vascular endothelial growth factor (VEGF), tumor necrosis 
factor-α (TNF-α) and endothelin-1 [4–9]. 
The evaluation of ascites extent is necessary for moni-
toring disease progression and for selecting appropriate 
treatment methods.
MATERIAL AND METHODS
Characteristics of ascites index  
and its application
This was a prospective observational concept-proof 
study verifying the usefulness of Ascites Index (AsI), a new 
tool for the quantitative determination of ascites in patients 
with OHSS, compared to the methods commonly used, to 
obtain data for planning further trials. 
The study group consisted of patients after controlled 
ovarian hyperstimulation diagnosed with the severe form 
of OHSS accompanied by ascites. The patients were hos-
pitalized in the 3rd Chair and Department of Gynecology, 
Teaching Hospital no. 4, Medical University of Lublin in the 
years 2011–2015 due to OHSS.
Inclusion criteria were enlarged ovary (> 7 cm in di-
ameter), hematocrit > 45%, WBC > 15,000/mm3, oliguria 
(< 400 mL urine per day), creatinine 1.0–1.5 mg/dL, creati-
nine clearance > 50 mL/min, estradiol > 5000 pg/mL, severe 
abdominal pain (≥ 6 point by VAS score), respiratory disor-
ders (dyspnea) and increasing ascites (in physical examina-
tion — symmetrical abdominal distension and succussion 
splash) [7–9]. The exclusion criteria were lack of indications 
for paracentesis.
Body weight, height and abdominal circumference were 
measured in all patients. Moreover, the Body Mass Index 
(BMI) was calculated.
Ultrasound measurements of ascites level were performed 
through the abdominal wall by one, experienced gynecologist 
(P.S.) with 23 years of experience in ultrasound in gynecology 
and obstetrics, using a transabdominal convex ultrasound 
transducer C3-7IM (frequency range: 3–7 MHz; field of view: 
78 degrees) (Medison Accuvix V10/Medison Accuvix V20 Pres-
tige — Seoul, South Korea) and SC1-6 (frequency range: 
1–6 MHz; field of view: 60 degrees) (Medison UGEO WS80A 
Elite — Seoul, South Korea). Examinations were carried out in 
the dorsal decubitus position without any special preparation 
of patients. The depth of free fluid pockets was measured per-
pendicularly to the abdominal circumference tangent (Fig. 1A).
Free fluid areas were found to be located between the 
diaphragmatic domes, diaphragmatic surface of the right 
hepatic lobe (upper, right quadrant) and diaphragmatic 
surface of the spleen (upper, left quadrant) as well as in 
both iliac fossae between the pelvis minor wall, ascending 
colon (lower, right quadrant) and descending colon (lower, 
left quadrant) (Fig. 1B).
Figure 1. A. Location of an ultrasound probe during AsI examination. B. Anatomical location of ascitic fluid pockets in the peritoneal cavity (orange color)
A B
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Figure 2. Measurements of the depth of ascitic fluid pockets during ultrasound examination (in this case, AsI was 29.1 cm)
The values of four measurements were totaled giving 
the Ascites Index (AsI), similarly to the Amniotic Fluid Index 
(AFI). The AsI values were presented in centimeters (Fig. 2). 
The study design was approved by the Local Bioeth-
ics Committee (KE-0254/161/2015) and each patient gave 
informed consent for participation in the study.
Due to dyspnea, all studied patients underwent para-
centesis. To avoid complications associated with excessive 
protein loss, 2000 mL of fluid was removed at one time in 
each patient. Standard treatment was instituted [3, 4, 10]. 
Using body weight, BMI, abdominal circumference and 
AsI measurements, the extent of ascites was monitored to 
evaluate disease progression. Ascites in all patients were 
monitored until the symptoms of OHSS subsided.
Descriptive data were shown as median (range) due to 
non-normal distribution. Body weight, BMI, abdominal circum-
ference and AsI of patients before and after paracentesis were 
compared applying the Wilcoxon signed-rank test. Correla-
tions between AsI and the remaining parameters were tested 
by the Spearman’s Rho test. Statistical analysis was performed 
using Statistica software (version 10, Statsoft, Tulsa, OK, USA).
RESULTS
In the analyzed period, 14 patients with OHSS were hos-
pitalized. The study included 12 Caucasian female patients 
aged 26–34 years. Two patients were excluded from the 
study. All patients underwent controlled ovarian hyper-
stimulation prior to an in vitro fertilization programme. In all 
patients a short agonist protocol to stimulate ovulation was 
used. Moreover, administering chorionic gonadotropin-al-
pha was abandoned in all patients due to increased risk of 
OHSS (serum concentration of estradiol > 5000 pg/mL).
Median AsI in patients reporting dyspnea was 29.0 cm 
(range 21.6–38.6 cm) and after paracentesis — 12.9 cm 
(range 12.1–14.5 cm). At AsI values less than 21.6 cm, no 
dyspnea was observed in any of the 12 studied patients. Me-
dian of AsI percentage decrease after paracentesis was 
55.5 % (range 43.5–62.4 %). Median of percentage decrease 
remaining methods of ascites monitoring (body weight, BMI 
and abdominal circumference) after paracentesis was less 
than 5% in all cases (Tab. 1).
The difference in AsI, body weight, BMI and abdominal 
circumference before and after paracentesis was statistically 
significant (p < 0.05) (Tab. 1).
There were no statistically significant correlations be-
tween AsI and the remaining methods of ascites monitoring 
before and after paracentesis (Tab. 2). 
The detailed results are presented in Table 1 and 2. 
DISCUSSION
The value of the lower range of AsI at the time of qualifi-
cation for paracentesis was 21.6 cm. Below this AsI value, we 
did not observe dyspnea in the study patients and puncture 
of the peritoneal cavity was not necessary. This applied to 
two patients who were excluded from the study (AsI was 
less than 19.0 cm during hospitalization).
The observed difference AsI pre- and post-paracentesis 
was statistically significant. Median of percentage decrease 
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anthropometric methods of ascites monitoring (body 
weight, BMI and abdominal circumference) after paracen-
tesis was less than 5%. With such a small difference, these 
methods require very precise measurements. Taking into 
account the occurrences of observational error, commonly 
used anthropometric methods may be imprecise [11].
The Spearman correlation between AsI and parallel stud-
ied anthropometric parameters (weight, BMI, abdominal 
circumference) were not statistically significant (Tab. 2). It 
allows to conclude that in the study group AsI was inde-
pendent of observed anthropometric parameters.
It is important to note that OHSS may be a life-threat-
ening complication and during controlled ovarian hyper-
stimulation it is important to minimize the risk of it. However, 
OHSS is a rare complication and obtaining high numbers in 
studies investigating this pathology is difficult.
While the mere diagnosis of ascites using the diagnostic 
methods available is not a problem, quantitative evaluation 
of the ascites volume is. The peritoneal cavity is roughly 
spherical, whereas the organs situated in it make its shape 
irregular. Therefore, calculations of the volume of ascites are 
a diagnostic problem. The usefulness of quantitative evalu-
ation of ascites seems grounded for assessing treatment 
outcomes, monitoring fluid increases and earlier planning 
of decompression procedures [12].
The physical examination is often inaccurate for assess-
ment of ascites and additional diagnostic procedures are 
required [13]. Non-invasive diagnostic procedures, such as 
computed tomography or ultrasound examination, are sen-
sitive and specific for ascites diagnosis albeit expensive and 
currently unable to assess the extent of ascites. The indicator 
dilution technique (IDT) can be used to calculate the volume 
of ascites. IDT is performed by quantitative injection of an in-
dicator into the ascitic fluid and subsequent sampling here. 
The indicator should be a protein bounded tracer or protein 
bounded dye. After the injection, the abdomen is carefully 
kneaded and samples of ascitic fluid ate taken 20–60 min-
utes after indicator injection. The volume of ascites is calcu-
lated from the difference in the dilution of the indicator. The 
method carries the risk of infection, perforation of intestines 
or hemorrhage [12, 14]. To date, the methods of monitoring 
ascites included series measurements of body weight, ab-
dominal circumference and protrusion index, i.e. subjective 
scoring evaluation of compression-induced deflection of 
abdominal integuments measured in the line between the 
xiphoid process and pubic symphysis. Weight changes can 
Table 1. The study parameters in patients with OHSS before and after paracentesis
Parameters Median Range P
Pre-procedure body weight (kg) 60.7 53.0–86.5
< 0.05
Post-procedure body weight (kg) 57.9 50.3–84.0
Post-procedure weight loss (%) 4.6 2.9–6.6 N/A
Pre-procedure BMI (kg/m2) 21.9 20.2–31.4
< 0.05
Post-procedure BMI (kg/m2) 20.8 18.9–30.5
Post-procedure BMI decrease (%) 4.6 2.9–6.6 N/A
Pre-procedure abdominal circumference (cm) 89.4 86.1–101.6
< 0.05
Post-procedure abdominal circumference (cm) 86.6 82.9–96.2
Post-procedure abdominal circumference decrease (%) 3.3 1.4–5.3 N/A
Pre-procedure AsI (cm) 29.0 21.6–38.6
< 0.05
Post-procedure AsI (cm) 12.9 12.1–14.5
Post-procedure AsI decrease (%) 55.5 43.5–62.4 N/A
Table 2. Spearman’s correlation coefficient (Rho) for AsI and the parameters studied before and after paracentesis
Parameters Spearman’s Rho p
AsI before paracentesis /body weight before paracentesis –0.29 NS
AsI after paracentesis/body weight after paracentesis –0.32 NS
AsI before paracentesis/BMI before paracentesis 0.24 NS
AsI after paracentesis/BMI after paracentesis 0.07 NS
AsI before paracentesis/abdominal circumference before paracentesis –0.26 NS
AsI after paracentesis/abdominal circumference after paracentesis –0.30 NS
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indirectly indicate decreasing or increasing ascites. Moreover, 
changes in body weight and structure can be affected by the 
course of disease inducing ascites and the way of its treat-
ment. Furthermore, abdominal circumference measurements 
and the protrusion index assume that both the amount of 
fatty tissue and muscle mass do not change [15, 16].
The International Ascites Club (IAC) proposed a clas-
sification, in which ascites was divided into uncomplicated 
and refractory. Uncomplicated ascites is not infected and 
is unrelated to the development of hepatorenal syndrome. 
Grade 1 uncomplicated ascites is mild and detectable only 
on ultrasound; grade 2 is moderate ascites manifesting as 
slight, symmetrical abdominal distension; grade 3 ascites is 
evidenced by noticeably marked distension. According to 
the IAC, refractory ascites is resistant to pharmacological 
treatment, tends to recur and occurs in about 5–10% of all 
ascites cases [17]. The classification by IAC seems of little use 
in OHSS cases since it is suitable for taking proper therapeu-
tic algorithms rather than treatment monitoring. Moreover, 
in its severe and critical forms, ascites in the course of OHSS 
is resistant and hardly ever responses to pharmacological 
therapy alone.
Ultrasound examinations substantially widen the op-
tions of ascites evaluation and enable the localization of 
free fluid [18].
Ultrasound with a vaginal probe for assessment of the 
free fluid amount in the peritoneal cavity is commonly used 
by gynecologists, not only in OHSS cases. Decubitus meas-
urements of pockets of free fluid located in the uterovesical 
or rectouterine pouch (the Douglas pouch), followed by 
evaluation of fluid volume based on 3 dimensions (width, 
depth, height), are precise yet have some limitations. The 
amount of fluid that can be assessed using this method is 
small, a range 8–300 mL. In cases of larger fluid amounts, 
usually present in ascites, the range of penetration of the 
vaginal probe is too small and the use of transabdominal 
probe is almost always required [19–21].
Ultrasound evaluation of ascites volume using the 
transabdominal probe, described by Inadomi et al., is com-
plicated and time-consuming. Patients have to be placed in 
a horizontal position with the stomach down and support on 
hands and knees for 10 minutes. In this position, the ascitic 
fluid collects in the lowest point between the intestinal sur-
face and the posterior surface of the anterior abdominal wall. 
The examination is performed with a linear probe along the 
anterior abdominal wall upwards. The largest fluid pocket 
should be found and measured. Next, the abdominal circum-
ference is measured. It is assumed that the abdominal cavity 
is modelled as a sphere and the volume is calculated accord-
ing to the formula: ascitic fluid volume = 1/3[πd2 (3r–d)], 
where „d” is the width of the largest fluid pocket and „r” is the 
radius of the abdominal cavity, calculated using the formula 
(r = abdominal circumference/2π) [12].
Moreover, simpler ultrasound methods evaluating as-
cites extent with the use of a transabdominal probe have 
been described in literature. Irshad et al. measured the depth 
of a single free fluid pocket at the site of paracentesis from 
the abdominal cavity wall to the most superficial intestinal 
loop before and after the procedure. It has been demon-
strated that pre- and post-procedure pocket depths are 
correlated and can be used for evaluation of ascitic fluid 
extent in ultrasound examinations [22].
Gerbes et al. proposed a method of evaluating ascites 
extent, used in gastroenterology, in which the dimension of 
the Morrison recess is assessed, i.e. the potential peritoneal 
recess between the lower liver edge and kidney. The exami-
nation involves the right epigastrium and is performed in 
a left lateral decubitus position. The authors have demon-
strated the clinical usefulness of the method for monitoring 
ascites treatment [23].
Based on the method used in the presented study, Alnu-
meiri et al. suggested the following possible evaluation of 
ascites volume: after imaging free fluid spaces in the external 
quadrants of the abdomen, the ascitic fluid volume was esti-
mated using 2 and 3 dimensions (width, depth and height). 
The sum of the individual measurements provided the total 
estimated abdominal ascites (TEAA). The method allowed to 
categorize ascites into 4 grades: I (mild, TEAA < 200–600 mL), 
II (moderate, TEAA > 600–800 mL), III (severe, TEAA > 800– 
–1000 mL), IV (massive, TEAA > 1000–2000 mL). The authors 
concluded that ascites grade (using ultrasound evaluation of 
ascitic fluid volume) could reflect the disease etiology [24].
Furthermore, the 5-grade evaluation of ascites volume 
was proposed based on computed tomography in patients 
with neoplastic ascites. Having performed a series of trans-
verse sections of the abdominal cavity, the width of fluid 
pockets is measured in five places — on both sides in sub-
diaphragmatic spaces (points A and B) and paracolonic 
spaces (points C and D) as well as in the space between the 
pubic symphysis and urinary bladder (point E). The subdia-
phragmatic and paracolonic measurements are performed 
in the transverse section while the space in front of the 
urinary bladder — in the sagittal section. The volume of 
ascites is calculated according to the following formula: fluid 
volume = ([A + B + C + D + E] × 200 [mL]) [25].
Computed tomography enables the use a 3D rendering 
technique to calculate ascites volume, which provides most 
reliable data, as compared to other methods described 
above [25].
The AsI method applies the physical law formulated 
by Blaise Pascal in the 17th century (known as the Pascal’s 
law). According to this law, the peritoneal cavity is a closed 
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spherical reservoir and the fluid inside exerts external pres-
sure, hence the pressure is equal inside the reservoir and it 
equals the external pressure. The law results from the fact 
that fluid particles can move in any direction and the pres-
sure put from one side changes the movement of particles 
in all directions [26]. As a result, free fluid in the peritoneal 
cavity during pressure equalization passes under the dia-
phragmatic domes and into both iliac fossae, moving the 
liver, spleen and intestinal loops medially and forming free 
fluid pockets (Fig. 1B). The AsI-measured depth of pock-
ets depends on the fluid pressure in the peritoneal cavity 
whereas the pressure is directly dependent on its amount. 
Considering the assumptions presented and fixed location 
of abdominal organs, the rule is — the higher the amount 
of fluid in the peritoneal cavity, the higher the AsI value.
From the clinical point of view, it is unnecessary to know 
the volume of fluid in the peritoneal cavity to evaluate the 
extent of ascites, which has been suggested by some au-
thors mentioned above [12, 24, 25]. Even on qualification for 
paracentesis, the fluid volume is irrelevant as during decom-
pression punctures the peritoneal cavity is not completely 
emptied, and only the amount of fluid released is limited 
due to simultaneous loss of albumins. The above-mentioned 
statement is relevant not only in OHSS but also in other 
diseases with ascites [3, 4, 27]. 
Computed tomography is an alternative technique to 
estimate ascitic fluid volume but lasts longer than the as-
sessment of AsI and requires position changes, what can be 
inconvenient for ascites patients. Moreover, computed to-
mography is expensive and contraindicated in pregnancy. 
In OHSS patients, pregnancy cannot be excluded in all cases.
Ultrasound examinations assessing only the size of one 
fluid space are equally simple and quick but do not allow 
to evaluate the distribution of fluid in the peritoneal cavity.
Comparison of pre- and post-paracentesis AsI values and 
the methods used to date (measurements of body weight, 
BMI and abdominal circumference) revealed their statisti-
cally significant difference, which suggests the AsI method 
equally useful for monitoring ascites treatment. 
The lack of AsI correlation with body weight, BMI and 
abdominal circumference allows to anticipate the develop-
ment of ascites, irrespective of anthropometric character-
istics of patients.
Ascites occurs in 15–50% of patients with neoplastic 
diseases (ovarian, endometrial, breast, colon, stomach and 
pancreas cancer). Less common neoplastic causes of ascites 
include non-Hodgkin lymphoma, prostate cancer, meso-
thelioma, multiple myeloma and malignant melanoma. 
Furthermore, ascites can be induced by non-neoplastic dis-
eases, such as portal hypertension, portal vein thrombosis, 
congestive heart failure, nephrotic syndrome, pancreatitis, 
tuberculosis and intestinal perforation [28–30]. The diseases 
mentioned above, as well as their treatment, significantly 
affect the changes in body weight and structure, which 
affect both the amount of fatty tissue and also bone and 
muscle mass [31–33].
Considering the lack of AsI relation to body weight 
can be useful for monitoring ascites during treatment in 
cases other than OHSS. However, this thesis should be veri-
fied in the group of patients with low and high BMI, because 
the study did not include a representative group of patients 
with low and high BMI.
CONCLUSIONS
To conclude, the methods of monitoring the extent and 
treatment of ascites involving serial measurements of body 
weight and abdominal circumference may be imprecise. 
Therefore, it seems that an accurate and easy implement 
tool, which could objectively and quantitatively evaluate 
the extent of ascites using the basic ultrasound equipment, 
may be useful for evaluating of OHSS course and treatment 
outcomes.
The proposed AsI seems to be a promising tool for esti-
mating and monitoring the ascites extent in OHSS. It can be 
estimated using basic ultrasound equipment. Furthermore, 
this technique may be easily used in outpatient setting.
AsI requires further studies in order to standardization 
and transferability to other causes of ascites.
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